MicroTransponder Inc.:企業の製品開発パイプライン分析2014

◆英語タイトル:MicroTransponder Inc. - Product Pipeline Analysis, 2014 Update
◆商品コード:GDME16386PD
◆発行会社(調査会社):GlobalData
◆発行日:2014年10月27日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

MicroTransponder Inc. (MicroTransponder) is a medical device company. The company develops neurostimulation solutions to treat neurological diseases. Its lead product serenity system is used to treat tinnitus. MicroTransponder’s product serenity system combines with an existing therapy called vagus nerve stimulation. The product has been used to treat many patients for depression and epilepsy. The company also conducts research and development activities. It is a part of University of Texas at Dallas. MicroTransponder is headquartered in Houston, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MicroTransponder Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
MicroTransponder Inc. Company Snapshot 4
MicroTransponder Inc. Company Overview 4
Key Information 4
MicroTransponder Inc. Pipeline Products and Clinical Trials Overview 5
MicroTransponder Inc. – Pipeline Analysis Overview 8
Key Facts 8
MicroTransponder Inc. – Major Products and Services 9
MicroTransponder Inc. Pipeline Products by Development Stage 10
MicroTransponder Inc. Clinical Trials by Trial Status 12
MicroTransponder Inc. Pipeline Products Overview 14
SAINT System – Anxiety Disorders 14
SAINT System – Anxiety Disorders Product Overview 14
SAINT System – Chronic Pain 15
SAINT System – Chronic Pain Product Overview 15
SAINT System – Motor And Speech Deficit 16
SAINT System – Motor And Speech Deficit Product Overview 16
SAINT System – Tinnitus 17
SAINT System – Tinnitus Product Overview 17
SAINT System – Urinary Incontinence 18
SAINT System – Urinary Incontinence Product Overview 18
Serenity System – Post Stroke Motor Rehabilitation 19
Serenity System – Post Stroke Motor Rehabilitation Product Overview 19
Serenity System – Tinnitus 20
Serenity System – Tinnitus Product Overview 20
Serenity System – Tinnitus Clinical Trial 21
Vivistim Device 22
Vivistim Device Product Overview 22
Vivistim Device Clinical Trial 23
MicroTransponder Inc. – Key Competitors 24
MicroTransponder Inc. – Key Employees 25
MicroTransponder Inc. – Locations And Subsidiaries 26
Head Office 26
Recent Developments 26
MicroTransponder Inc., Recent Developments 26
May 15, 2009: MicroTransponder To Develop A Tiny Device To Treat Chronic Pain 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
MicroTransponder Inc., Key Facts 4
MicroTransponder Inc. Pipeline Products and Clinical Trials Overview 5
MicroTransponder Inc. Pipeline Products by Equipment Type 6
MicroTransponder Inc. Pipeline Products by Indication 7
MicroTransponder Inc. Clinical Trials by Trial Status 7
MicroTransponder Inc., Key Facts 8
MicroTransponder Inc., Major Products and Services 9
MicroTransponder Inc. Number of Pipeline Products by Development Stage 10
MicroTransponder Inc. Pipeline Products Summary by Development Stage 11
MicroTransponder Inc. Clinical Trials by Trial Status 12
MicroTransponder Inc. Clinical Trials Summary 13
SAINT System - Anxiety Disorders - Product Status 14
SAINT System - Anxiety Disorders - Product Description 14
SAINT System - Chronic Pain - Product Status 15
SAINT System - Chronic Pain - Product Description 15
SAINT System - Motor And Speech Deficit - Product Status 16
SAINT System - Motor And Speech Deficit - Product Description 16
SAINT System - Tinnitus - Product Status 17
SAINT System - Tinnitus - Product Description 17
SAINT System - Urinary Incontinence - Product Status 18
SAINT System - Urinary Incontinence - Product Description 18
Serenity System - Post Stroke Motor Rehabilitation - Product Status 19
Serenity System - Post Stroke Motor Rehabilitation - Product Description 19
Serenity System - Tinnitus - Product Status 20
Serenity System - Tinnitus - Product Description 20
Serenity System - Tinnitus - A Blinded Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired with Tones for Tinnitus Versus VNS with Unpaired Tones 21
Vivistim Device - Product Status 22
Vivistim Device - Product Description 22
Vivistim Device - A Proof-of-concept Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired with Rehabilitation for Improved Upper Limb Function After Stroke (MicroTransponder's Vivistim System) 23
MicroTransponder Inc., Key Employees 25

List of Figures
MicroTransponder Inc. Pipeline Products by Equipment Type 6
MicroTransponder Inc. Pipeline Products by Development Stage 10
MicroTransponder Inc. Clinical Trials by Trial Status 12

★調査レポート[MicroTransponder Inc.:企業の製品開発パイプライン分析2014] (コード:GDME16386PD)販売に関する免責事項を必ずご確認ください。
★調査レポート[MicroTransponder Inc.:企業の製品開発パイプライン分析2014]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆